Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2

Conditions

Neoplasms 4Venous Thrombosis 2Venous Thromboembolism 2Pulmonary Embolism 2Thrombosis 1Small Cell Lung Carcinoma 1Hemorrhage 1Carcinoma, Small Cell 1

Interventions

apixaban 22Rivaroxaban 16Dalteparin 16Enoxaparin 11Heparin, Low-Molecular-Weight 10Tinzaparin 8Aspirin 8Fondaparinux 4Dabigatran 4edoxaban 3Warfarin 3Nadroparin 3bemiparin 2abelacimab 2Rosuvastatin Calcium 2Observation 2MAA868 2sotorasib 1ribociclib 1reviparin 1palbociclib 1isoquercitrin 1enoxaparin sodium 1certoparin 1calcium heparin 1betrixaban 1argatroban 1acarboxyprothrombin 1abemaciclib 1Tacrolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Venous Thromboembolism × bemiparin × Clear all
NCT01164046 2014-12-03

Longheva

University Medical Center Groningen

Phase 3 Terminated
56 enrolled
Classical hematology

Neoplasms, Venous Thrombosis, Venous Thromboembolism

NCT00219973 2010-04-28

CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)

Rovi Pharmaceuticals Laboratories

Phase 3 Completed
526 enrolled
Classical hematology

Hemorrhage, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡